Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02151825 · ClinicalTrials.gov registry record · NA
Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects
A NA study of Adiposity and Gut -Microbiota, sponsored by Texas State University, San Marcos.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
- 1
- Study location
NCT02151825: Completed NA study of Adiposity and Gut -Microbiota, sponsored by Texas State University, San Marcos.
NCT02151825 is a NA study of Adiposity and Gut -Microbiota that has completed, run by Texas State University, San Marcos. The registered enrollment target is 54 participants, below the 96-participant average among 11 other Adiposity trials with a reported enrollment target (44% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02151825, a NA study of Adiposity and Gut -Microbiota, has completed, sponsored by Texas State University, San Marcos.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the effects of a synbiotic (ProSynbiotic) on the gut microbiota composition, body composition and adiposity-related genes and metabolic markers in healthy overweight adult subjects.
Primary Outcome
The primary objective of this study is to determine the effect of a synbiotic formulation called ProSynbiotic (administered at 3 capsules/day) containing 4 billion CFU of a probiotic blend of Bifidobacterium lactis BB-12, Lactobacillus acidophilus LA-5, Lactobacillus casei 431 and Saccharomyces boulardii, along with 1 g of the prebiotic inulin and 100 mg of galactooligosaccharide (GOS) on the gut microbiota of healthy overweight adult subjects when compared to a placebo of maltodextrin. Changes
Conditions Studied
Interventions
- OTHER Placebo
- DIETARY_SUPPLEMENT Synbiotic
Study Locations (1)
Texas
- Texas State University - San Marcos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2011-09 |
| Est. Completion | 2012-10 |
| Phase | NA |
What the finished NCT02151825 record still lists
NCT02151825 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 54 participants, a relatively small participant target, below the 96-participant average among 11 other Adiposity trials with a reported enrollment target (44% lower).
The record links to 2 conditions, with Adiposity appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02151825 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02151825 about?
NCT02151825 is a clinical study titled "Effect of a Synbiotic on the Gut Microbiota and Adiposity-related Markers in Healthy Overweight Subjects". The purpose of this study is to investigate the effects of a synbiotic (ProSynbiotic) on the gut microbiota composition, body composition and adiposity-related genes and metabolic markers in healthy overweight adult subjects.
What is the current status of trial NCT02151825?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2011-09. Estimated completion is 2012-10.
What conditions does trial NCT02151825 study?
This clinical trial studies the following conditions: Adiposity, Gut -Microbiota.
What interventions are being tested in trial NCT02151825?
The interventions under investigation include: Placebo (OTHER), Synbiotic (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02151825?
This trial is sponsored by Texas State University, San Marcos, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02151825 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Adiposity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02151825's enrollment target sits among peer trials
54 5th of 11 higher than 7 of 11 other Adiposity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Adiposity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The Influence of Chardonnay Marc Intake on Gut and Cardiometabolic Health
RECRUITING · NA
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Redefining BMI: The Body, Mind, and Inflammation Trial
RECRUITING · NA
-
The Sweet Kids Study (Stevia on Weight and Energy Effect Over Time)
RECRUITING · NA
-
Serial Assessment of Body Fat Accrual in Very Preterm Infants
ACTIVE NOT RECRUITING · NA
-
Endoscopic Gastric Mucosal Ablation as a Primary Obesity Therapy
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01269853 · 54 participants · Phase 1
Repeated Super-selective Intraarterial Cerebral Infusion of Bevacizumab (Avastin) for Treatment of Relapsed GBM and AA
- NCT02390752 · 54 participants · Phase 1
Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- NCT02991248 · 54 participants · NA
Improve Dynamic Lateral Balance of Humans With SCI
- NCT02993900 · 54 participants · NA
Image-Guided Gynecologic Brachytherapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia